Delivery Order SPE2DE24D0013-SPE2D625F2NLC
- Not listed
- The U.S. Defense Department's Medical Supply Chain organization awarded a delivery order valued at $1,190.28 to Cepheid Inc. on August 14, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order does not utilize any set-aside designation and represents a discrete procurement under a broader federal vehicle. Cepheid, a molecular diagnostics manufacturer based in Sunnyvale, California, specializes in providing advanced diagnostic systems and test kits for...
- The U.S. Defense Department's Medical Supply Chain division awarded a $29,520 firm fixed-price delivery order to Cepheid Inc. on August 28, 2025, with an ultimate completion date of September 5, 2025. The contract, which carries no set-aside designation, is for molecular diagnostic solutions to be performed at Cepheid's facility in Sunnyvale, California. Cepheid, a for-profit manufacturer of advanced diagnostic systems and test kits, specializes in detecting infectious diseases and clinical...
- The U.S. Defense Department's Medical Supply Chain awarded a $27,235.80 firm fixed-price delivery order to Cepheid Inc. on June 6, 2025, with an ultimate completion date of June 13, 2025. This delivery order, issued under contract number XPRSMVP-10, carries no set-aside designation and represents work to be performed at Cepheid's headquarters in Sunnyvale, California. Cepheid is a leading manufacturer of molecular diagnostic solutions, specializing in advanced GeneXpert diagnostic systems and...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $1,800 firm fixed-price delivery order to Cepheid Inc., a leading molecular diagnostics manufacturer headquartered in Sunnyvale, California. This delivery order, issued on August 25, 2025, with an ultimate completion date of September 2, 2025, carries no set-aside designation and represents a continuation of the agency's procurement of advanced diagnostic solutions. The work will be performed at Cepheid's Sunnyvale facility....
- The U.S. Defense Department's Medical Supply Chain organization awarded Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, a $4,108.25 firm fixed-price delivery order (Contract No. 4569031063) on August 7, 2025, with completion scheduled for August 14, 2025. This delivery order carries no set-aside designation and represents a procurement of diagnostic solutions from Cepheid's established product portfolio. The award leverages Cepheid's expertise in molecular...
- The U.S. Defense Department's Medical Supply Chain has awarded a $5,082 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, for SARS-CoV-2 testing supplies. The contract, awarded on August 4, 2025, with an ultimate completion date of August 18, 2025, carries no set-aside designation and will be performed at Cepheid's primary facility in Sunnyvale. This delivery order falls under Cepheid's existing indefinite delivery vehicle...
- The U.S. Defense Medical Supply Chain awarded a $13.6K delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on September 2, 2025, with completion targeted for September 9, 2025. This firm fixed-price delivery order (Contract No. 4569302261) procures diagnostic testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract carries no set-aside designation and represents a continuation of...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $1,854.00 by the Medical Supply Chain (a Defense agency) on May 21, 2025, with an ultimate completion date of May 29, 2025. The contract, issued without set-aside designation under contract number GXGBSLBXC-10, is to be performed in Sunnyvale, California. This delivery order represents a discrete procurement action under one of Cepheid's existing...
- Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,040 on September 10, 2025, by the Medical Supply Chain, a defense-focused federal agency. This delivery order, designated XPCOV2/FLU/RSV-10 with an ultimate completion date of September 17, 2025, is associated with Cepheid's larger Indefinite Delivery Vehicle (IDV) contract with the Veterans Affairs Veterans Integrated Service Network 21, valued at $2.5...
- The U.S. Defense Department's Medical Supply Chain awarded a $1,930.72 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on May 2, 2025, with an ultimate completion date of May 9, 2025. The contract, designated as XPRSMVP-10, carries no set-aside designation and represents a delivery order under one of Cepheid's existing Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs. Cepheid specializes in...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F2NLCDelivery Order
The U.S. Defense Department's Medical Supply Chain division awarded a firm fixed-price delivery order valued at $1,297.80 to Cepheid Inc. on September 4, 2025, with an ultimate completion date of September 11, 2025. The award, contract number GXGBSLBXC-10, carries no set-aside designation and will be performed in Sunnyvale, California, where Cepheid maintains its headquarters. As a leading manufacturer of molecular diagnostic solutions, Cepheid specializes in advanced diagnostic systems and test kits for infectious diseases, genetic conditions, and clinical testing, making it well-positioned to support defense healthcare supply chain requirements. This delivery order likely represents a task order issued against one of Cepheid's existing Indefinite Delivery Vehicle contracts, which provide a framework for ongoing procurement of molecular diagnostic equipment, reagents, and related services. Cepheid maintains significant IDV agreements with the Department of Veterans Affairs, including a $32.8M contract with VA's Veterans Integrated Service Network 6 and a $2.5M contract with Veterans Integrated Service Network 21, both structured as firm fixed-price vehicles. The company's federal contract portfolio demonstrates consistent engagement across multiple defense and civilian healthcare agencies, delivering diagnostic testing solutions for COVID-19, influenza, respiratory syncytial virus, and other infectious diseases essential to military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/4/25 |